Press release
Sensorineural Hearing Loss Clinical Trials | A Drug Pipeline Analysis Report 2024 | Sensorion, AudioCure Pharma, Audion Therapeutics, Reyon Pharmaceutical, Decibel Therapeutics, Sound Pharmaceuticals, Otonomy, Pipeline Therapeutics, Heyu (Suzhou) Pharmace
Sensorineural Hearing Loss Clinical Trials
Request for a sample report @ https://www.delveinsight.com/report-store/sensorineural-hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Key Takeaways from the Sensorineural Hearing Loss Pipeline Report
Over 21+ Sensorineural Hearing Loss pipeline therapies are in various stages of development, and their anticipated acceptance in the Sensorineural Hearing Loss market would significantly increase market revenue.
Leading Sensorineural Hearing Loss companies developing novel drug candidates to improve the Sensorineural Hearing Loss treatment landscape include Pipeline Therapeutics, Audion Therapeutics, Otonomy, and others.
Promising Sensorineural Hearing Loss pipeline therapies in various stages of development include PIPE 505, LY 3056480, OTO 413, and others.
Sensorineural Hearing Loss Overview
Sensorineural Hearing Loss (SHL) is caused by damage to the structures in your inner ear or your auditory nerve. It is responsible for more than 90 percent of hearing loss in adults. Common causes of SHL include exposure to loud noises, genetic factors, or the natural aging process. Individuals with SHL may experience difficulties in understanding speech, hearing faint sounds, or distinguishing between different sounds. Diagnosis typically involves a comprehensive hearing evaluation by an audiologist, which may include a physical examination, hearing tests, and imaging studies.
SHL is characterized by various signs and symptoms that can impact an individual's auditory experience. Common indicators of SHL include difficulty understanding speech, muffled hearing, a sensation of fullness in the ear, and a gradual or sudden loss of hearing. Additionally, individuals with SHL may struggle to follow conversations in noisy environments, experience a ringing or buzzing sound in the ears (tinnitus), find it challenging to differentiate between high-pitched sounds, and perceive voices as mumbled or slurred.
Currently, there is no surgical option to treat SHL. The most common treatment options are hearing aids and cochlear implants, which help compensate for hearing loss. Gene therapy for hearing loss is an expanding field of research, but it is not yet clinically used for SHL.
Download our report to know more about the pipeline segment @ https://www.delveinsight.com/report-store/sensorineural-hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Sensorineural Hearing Loss Emerging Drugs
SENS-401: Sensorion
SENS-401 is a first-in-class drug candidate to treat Sudden Sensorineural Hearing Loss (SSNHL). It is aiming at treating or protecting against inner ear lesions that lead to nerve degeneration and sensory hair cell loss. It is protected by a solid intellectual property with two patent families. The drug is currently being evaluated under Phase II/III clinical trial for the treatment of patients with Sensorineural Hearing Loss.
AC-102: AudioCure Pharma
AC-102 is a disease modifying novel molecule. Preclinical models have demonstrated the unique potential of AC102 to act beneficially upon three cell types of the inner ear which are critical for the hearing process: the sensory inner hair cells, the sensory outer hair cells and the acoustic nerve. The drug is currently being evaluated under Phase II clinical trial for the treatment of patients with Sensorineural Hearing Loss (SHL).
LY 3056480: Audion Therapeutics
Audion's lead candidate (LY 3056480) has undergone a thorough and extensive preclinical characterization in multiple model systems prior to initiation of the clinical studies. These studies include effects of the drug on damaged inner ear tissue, inner ear PK studies to determine drug exposure using different formulations and formal ototoxicity studies to exclude toxic effects on normal hair cells and inner ear tissues. The drug is currently being evaluated under Phase I/II clinical trial for the treatment of patients with Sensorineural Hearing Loss (SHL).
Discover more about the emerging Sensorineural Hearing Loss drugs @ https://www.delveinsight.com/sample-request/sensorineural-hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Sensorineural Hearing Loss Key Companies
Pipeline Therapeutics
Audion Therapeutics
Otonomy
Sensorineural Hearing Loss Pipeline Therapies
PIPE 505
LY 3056480
OTO 413
Sensorineural Hearing Loss Pipeline Therapeutics Assessment
By development stage
By product type
By route of administration
By molecule type
By MOA type
Scope of the Sensorineural Hearing Loss Pipeline Report
Coverage: Global
Key Sensorineural Hearing Loss Companies: Pipeline Therapeutics, Audion Therapeutics, Otonomy, and others
Key Sensorineural Hearing Loss Pipeline Therapies: PIPE 505, LY 3056480, OTO 413, and others
Find out more about the Sensorineural Hearing Loss treatment options in development @ https://www.delveinsight.com/sample-request/sensorineural-hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Table of Contents
1. Introduction
2. Executive Summary
3. Overview
4. Pipeline Therapeutics
5. Late-Stage Products (Phase III)
6. Mid-Stage Products (Phase II)
7. Early Stage Products (Phase I/II)
8. Preclinical Stage Products
9. Discovery Stage Products
10. Therapeutic Assessment
11. Inactive Products
12. Collaborations Assessment- Licensing / Partnering / Funding
13. Unmet Needs
14. Market Drivers and Barriers
15. Appendix
16. About DelveInsight
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
Contact Us
Kritika Rehani
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sensorineural Hearing Loss Clinical Trials | A Drug Pipeline Analysis Report 2024 | Sensorion, AudioCure Pharma, Audion Therapeutics, Reyon Pharmaceutical, Decibel Therapeutics, Sound Pharmaceuticals, Otonomy, Pipeline Therapeutics, Heyu (Suzhou) Pharmace here
News-ID: 3631706 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Hearing
Atlantic Hearing Care, Inc. Champions Hearing Health with Expert Audiologists & …
Image: https://www.globalnewslines.com/uploads/2025/08/1754924892.jpg
Swampscott & Peabody, MA - Atlantic Hearing Care, Inc., a locally owned, patient-centered leader in audiological services, is proud to reaffirm its unwavering commitment to superior hearing health care. With two convenient locations in Swampscott and Peabody, Massachusetts, the practice continues to elevate community access to comprehensive hearing evaluations, expert audiologist consultations, and a wide array of advanced hearing aids.
As hearing loss affects millions, impacting communication, cognition and emotional…
Audio Help Hearing Centers Elevates Hearing Care with Expert Audiologists and Ad …
Image: https://www.globalnewslines.com/uploads/2025/05/1748357801.jpg
NEW YORK, NY - Audio Help Hearing Centers, a trusted leader in hearing healthcare, continues to set the standard for excellence by offering comprehensive hearing services through its team of expert audiologists. With convenient locations across Chelsea, Columbus Circle, Park Avenue, Scarsdale, and Stamford, Audio Help remains committed to delivering personalized care and the latest in hearing aid technology.
At Audio Help Hearing Centers [https://www.audiohelphearing.com/], patients receive individualized attention from…
Dr George Hearing Centers Expands Hearing Solutions with Custom ITE And Canal He …
Image: https://www.globalnewslines.com/uploads/2025/03/1742895322.jpg
Dr. George Hearing Centers expands its offerings with discreet and high-quality solutions for hearing loss.
Larnaca - March 25, 2025 - Dr. George Hearing Centers recently announced their expansion of innovative hearing solutions with custom In-the-Ear (ITE) and Canal Hearing Aids. This addition to their product lineup reflects the company's endeavour to providing high-quality, personalised hearing care for individuals experiencing hearing loss. The lineup includes Invisible-in-the-canal (IIC), Completely-in-the-canal (CIC), In-the-canal…
Ontario Hearing Centers in Rochester, NY: Delivering Exceptional Hearing Care an …
Image: https://www.globalnewslines.com/uploads/2025/01/1737435436.jpg
Rochester, NY - Ontario Hearing Centers is proud to be a trusted provider of comprehensive hearing care in Rochester, NY. As a locally owned practice with decades of experience, Ontario Hearing Centers continues to set the standard for personalized audiology services and cutting-edge hearing aid technology in the region.
At the heart of Ontario Hearing Centers' success is its commitment to helping individuals improve their quality of life through better…
Global Wireless Hearing Aid Market Driving Future Growth on Wireless Hearing Aid …
Global Wireless Hearing Aid Market 2025:
Global Wireless Hearing Aid Industry Market professional research 2015-2025, is a report which provides the details about industry overview, industry chain, market size (sales, revenue, and growth rate), gross margin, major manufacturers, development trends and forecast.
PDF Copy Available at Disconted Price Check Discount @ https://www.marketgrowthinsight.com/discount/90344
The Global Wireless Hearing Aid Market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of…
Smart Hearing Aids Market Development Insight and Manufacturers Challenges By Ke …
Recent research and the current scenario as well as future market potential of "Global Smart Hearing Aids Market Professional Survey Report 2019".
The Smart Hearing Aids Market comprehensively describes the market and prognosticates it to depict a highly illustrious growth during the forthcoming years. The report offers in-depth analysis of current and future Smart Hearing Aids Market outlook across the globe. The report is projected to help readers with the regions…
